Glycemic Control and Potential Complications in Patients with Diabetes MellitusCARLOS R. HAMILTON, JR., MD, FACE President of the American College of Endocrinology
Professor of Internal medicine University of Texas Houston Medical School Carlos R. Hamilton, Jr., MD, FACE, has practiced clinical endocrinology and internal medicine, and he is the executive vice president of the University of Texas Health Science Center at Houston and a professor of internal medicine at the UT Houston Medical School. After graduating from Baylor College of Medicine, he completed his internship and residency at the Johns Hopkins Hospital, an endocrine fellowship at the Massachusetts General Hospital, and was chief resident in medicine at Hopkins. He was on the full-time faculty at Hopkins before serving two years as an endocrinologist at the Wilford Hall USAF Medical Center in San Antonio. He was in private practice for 26 years and was a clinical professor of medicine at Baylor College of Medicine before assuming his present position. Dr. Hamilton has been active in medical organizations primarily as an advocate for medical practice and patient's rights. He has been a member of the AACE board of directors and served as chair of the AACE legislative and regulatory committee. He has also served as president of the Texas Society of Internal Medicine, the Harris County Medical Society and as chair of the Texas Medical Association Political Action Committee. He has served as a trustee of the American Society of Internal Medicine, as a member of the ACP-ASIM Health and Public Policy Committee and as a member of the AMA Federation Advisory Committee. He served as the 2004–2005 AACE president and as a trustee of the American College of Endocrinology. He is a past president on the AACE board of directors and president-elect of the American College of Endocrinology. He is a member of the practicing physicians advisory council to the US Secretary of Health and Human Services for issues related to the Center of Medicare and Medicaid Services. He also serves on the health, medicine and research committee of the World Anti-Doping Agency, which oversees the international prohibitions of the use of hormones and performance enhancing substances in athletic competition.
Attending Physician
Methodist Academic Medical Associates The Methodist Hospital Houston, TX. Dale J. Hamilton, M.D. is attending physician at the Methodist Academic Medical Associates and the clinical service chief of the division of diabetes, obesity and lipids at The Methodist Hospital, Houston, TX. He came to the TMH Department of Medicine from Baylor College of Medicine where he was Associate Professor of medicine and director to the Baylor Methodist diabetes management program. He is a member of the national organization and a council member of the Houston chapter of the American Diabetes Association. He is an active member of the American college of Physicians and a Fellow of American College of Endocrinologists. Dr. Hamilton received his medical degree from St. Louis University in St. Louis, MO, and underwent medical residency at Baylor College of Medicine, Houston, TX. He completed post-residency fellowship training in diabetes and endocrinology at Baylor. He has held clinical and full-time faculty positions at BCM. At Baylor he lectured in pathophysiology to second-year medical students and in the therapeutics of diabetes to fourth year medical students. He was active in the endocrine fellowship training program where he developed a core reading curriculum for first-year fellows. Dr. Hamilton has participated in research related to diabetes. He was a co-investigator in the islet transplant program for patients with type 1 diabetes and unstable control. He has collaborated in pharmaceutical trials evaluating anti-hypertensive agents and oral hypoglycemic medications in the treatment of patients with type 2 diabetes. His research interests have turned to the pathophysiology and metabolic management of patients with diabetes and heart disease. He now has a trial investigating methods to improve inpatient diabetes control after heart surgery. He co-authored with a cardiologist and cardiovascular surgeon and recently published a review of diabetes after heart transplantation.
|
||